Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Mechanical Tests
1.2.3 Imaging Tests
1.2.4 In Vitro Diagnostics (IVD) Tests
1.3 Market by Application
1.3.1 Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Infectious Disease Diagnostics Market Perspective (2018-2033)
2.2 Global Respiratory Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Respiratory Infectious Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Respiratory Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Respiratory Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Respiratory Infectious Disease Diagnostics Market Dynamics
2.3.1 Respiratory Infectious Disease Diagnostics Industry Trends
2.3.2 Respiratory Infectious Disease Diagnostics Market Drivers
2.3.3 Respiratory Infectious Disease Diagnostics Market Challenges
2.3.4 Respiratory Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Respiratory Infectious Disease Diagnostics by Players
3.1.1 Global Respiratory Infectious Disease Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Respiratory Infectious Disease Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Respiratory Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Infectious Disease Diagnostics Revenue in 2022
3.5 Global Key Players of Respiratory Infectious Disease Diagnostics Head office and Area Served
3.6 Global Key Players of Respiratory Infectious Disease Diagnostics, Product and Application
3.7 Global Key Players of Respiratory Infectious Disease Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033)
5 Respiratory Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Respiratory Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
6.2 North America Respiratory Infectious Disease Diagnostics Market Size by Type
6.2.1 North America Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033)
6.2.3 North America Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
6.3 North America Respiratory Infectious Disease Diagnostics Market Size by Application
6.3.1 North America Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033)
6.3.3 North America Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
6.4 North America Respiratory Infectious Disease Diagnostics Market Size by Country
6.4.1 North America Respiratory Infectious Disease Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
7.2 Europe Respiratory Infectious Disease Diagnostics Market Size by Type
7.2.1 Europe Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
7.3 Europe Respiratory Infectious Disease Diagnostics Market Size by Application
7.3.1 Europe Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
7.4 Europe Respiratory Infectious Disease Diagnostics Market Size by Country
7.4.1 Europe Respiratory Infectious Disease Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
8.2 China Respiratory Infectious Disease Diagnostics Market Size by Type
8.2.1 China Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023)
8.2.2 China Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033)
8.2.3 China Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
8.3 China Respiratory Infectious Disease Diagnostics Market Size by Application
8.3.1 China Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023)
8.3.2 China Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033)
8.3.3 China Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
9.2 Asia Respiratory Infectious Disease Diagnostics Market Size by Type
9.2.1 Asia Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
9.3 Asia Respiratory Infectious Disease Diagnostics Market Size by Application
9.3.1 Asia Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
9.4 Asia Respiratory Infectious Disease Diagnostics Market Size by Region
9.4.1 Asia Respiratory Infectious Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Respiratory Infectious Disease Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Respiratory Infectious Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Developments
11.2 Thermo Fisher Scientific.
11.2.1 Thermo Fisher Scientific. Company Details
11.2.2 Thermo Fisher Scientific. Business Overview
11.2.3 Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Introduction
11.2.4 Thermo Fisher Scientific. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific. Recent Developments
11.3 Koninklijke Philips
11.3.1 Koninklijke Philips Company Details
11.3.2 Koninklijke Philips Business Overview
11.3.3 Koninklijke Philips Respiratory Infectious Disease Diagnostics Introduction
11.3.4 Koninklijke Philips Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.3.5 Koninklijke Philips Recent Developments
11.4 Cardinal Health
11.4.1 Cardinal Health Company Details
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Respiratory Infectious Disease Diagnostics Introduction
11.4.4 Cardinal Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.4.5 Cardinal Health Recent Developments
11.5 COSMED
11.5.1 COSMED Company Details
11.5.2 COSMED Business Overview
11.5.3 COSMED Respiratory Infectious Disease Diagnostics Introduction
11.5.4 COSMED Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.5.5 COSMED Recent Developments
11.6 Smiths Group
11.6.1 Smiths Group Company Details
11.6.2 Smiths Group Business Overview
11.6.3 Smiths Group Respiratory Infectious Disease Diagnostics Introduction
11.6.4 Smiths Group Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.6.5 Smiths Group Recent Developments
11.7 NIHON KOHDEN CORPORATION
11.7.1 NIHON KOHDEN CORPORATION Company Details
11.7.2 NIHON KOHDEN CORPORATION Business Overview
11.7.3 NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Introduction
11.7.4 NIHON KOHDEN CORPORATION Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.7.5 NIHON KOHDEN CORPORATION Recent Developments
11.8 Becton
11.8.1 Becton Company Details
11.8.2 Becton Business Overview
11.8.3 Becton Respiratory Infectious Disease Diagnostics Introduction
11.8.4 Becton Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.8.5 Becton Recent Developments
11.9 Dickinson
11.9.1 Dickinson Company Details
11.9.2 Dickinson Business Overview
11.9.3 Dickinson Respiratory Infectious Disease Diagnostics Introduction
11.9.4 Dickinson Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.9.5 Dickinson Recent Developments
11.10 F.Hoffmann
11.10.1 F.Hoffmann Company Details
11.10.2 F.Hoffmann Business Overview
11.10.3 F.Hoffmann Respiratory Infectious Disease Diagnostics Introduction
11.10.4 F.Hoffmann Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.10.5 F.Hoffmann Recent Developments
11.11 bioMérieux SA
11.11.1 bioMérieux SA Company Details
11.11.2 bioMérieux SA Business Overview
11.11.3 bioMérieux SA Respiratory Infectious Disease Diagnostics Introduction
11.11.4 bioMérieux SA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.11.5 bioMérieux SA Recent Developments
11.12 Bio-Rad Laboratories, Inc.
11.12.1 Bio-Rad Laboratories, Inc. Company Details
11.12.2 Bio-Rad Laboratories, Inc. Business Overview
11.12.3 Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Introduction
11.12.4 Bio-Rad Laboratories, Inc. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.12.5 Bio-Rad Laboratories, Inc. Recent Developments
11.13 Quidel Corporation
11.13.1 Quidel Corporation Company Details
11.13.2 Quidel Corporation Business Overview
11.13.3 Quidel Corporation Respiratory Infectious Disease Diagnostics Introduction
11.13.4 Quidel Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.13.5 Quidel Corporation Recent Developments
11.14 Siemens Healthcare GmbH
11.14.1 Siemens Healthcare GmbH Company Details
11.14.2 Siemens Healthcare GmbH Business Overview
11.14.3 Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Introduction
11.14.4 Siemens Healthcare GmbH Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.14.5 Siemens Healthcare GmbH Recent Developments
11.15 Danaher
11.15.1 Danaher Company Details
11.15.2 Danaher Business Overview
11.15.3 Danaher Respiratory Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.15.5 Danaher Recent Developments
11.16 Qiagen
11.16.1 Qiagen Company Details
11.16.2 Qiagen Business Overview
11.16.3 Qiagen Respiratory Infectious Disease Diagnostics Introduction
11.16.4 Qiagen Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.16.5 Qiagen Recent Developments
11.17 GENERAL ELECTRIC COMPANY
11.17.1 GENERAL ELECTRIC COMPANY Company Details
11.17.2 GENERAL ELECTRIC COMPANY Business Overview
11.17.3 GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Introduction
11.17.4 GENERAL ELECTRIC COMPANY Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.17.5 GENERAL ELECTRIC COMPANY Recent Developments
11.18 Medtronic
11.18.1 Medtronic Company Details
11.18.2 Medtronic Business Overview
11.18.3 Medtronic Respiratory Infectious Disease Diagnostics Introduction
11.18.4 Medtronic Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.18.5 Medtronic Recent Developments
11.19 Novartis AG
11.19.1 Novartis AG Company Details
11.19.2 Novartis AG Business Overview
11.19.3 Novartis AG Respiratory Infectious Disease Diagnostics Introduction
11.19.4 Novartis AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.19.5 Novartis AG Recent Developments
11.20 Johnson & Johnson Services Inc
11.20.1 Johnson & Johnson Services Inc Company Details
11.20.2 Johnson & Johnson Services Inc Business Overview
11.20.3 Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Introduction
11.20.4 Johnson & Johnson Services Inc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.20.5 Johnson & Johnson Services Inc Recent Developments
11.21 GlaxoSmithKline plc
11.21.1 GlaxoSmithKline plc Company Details
11.21.2 GlaxoSmithKline plc Business Overview
11.21.3 GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Introduction
11.21.4 GlaxoSmithKline plc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.21.5 GlaxoSmithKline plc Recent Developments
11.22 Drägerwerk AG & Co. KGaA
11.22.1 Drägerwerk AG & Co. KGaA Company Details
11.22.2 Drägerwerk AG & Co. KGaA Business Overview
11.22.3 Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Introduction
11.22.4 Drägerwerk AG & Co. KGaA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.22.5 Drägerwerk AG & Co. KGaA Recent Developments
11.23 GC Diagnostics Corporation
11.23.1 GC Diagnostics Corporation Company Details
11.23.2 GC Diagnostics Corporation Business Overview
11.23.3 GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Introduction
11.23.4 GC Diagnostics Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.23.5 GC Diagnostics Corporation Recent Developments
11.24 Bayer AG
11.24.1 Bayer AG Company Details
11.24.2 Bayer AG Business Overview
11.24.3 Bayer AG Respiratory Infectious Disease Diagnostics Introduction
11.24.4 Bayer AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.24.5 Bayer AG Recent Developments
11.25 Masimo
11.25.1 Masimo Company Details
11.25.2 Masimo Business Overview
11.25.3 Masimo Respiratory Infectious Disease Diagnostics Introduction
11.25.4 Masimo Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.25.5 Masimo Recent Developments
11.26 Carestream Health
11.26.1 Carestream Health Company Details
11.26.2 Carestream Health Business Overview
11.26.3 Carestream Health Respiratory Infectious Disease Diagnostics Introduction
11.26.4 Carestream Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023)
11.26.5 Carestream Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Mechanical Tests
Table 3. Key Players of Imaging Tests
Table 4. Key Players of In Vitro Diagnostics (IVD) Tests
Table 5. Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Respiratory Infectious Disease Diagnostics Market Share by Region (2018-2023)
Table 9. Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Respiratory Infectious Disease Diagnostics Market Share by Region (2024-2033)
Table 11. Respiratory Infectious Disease Diagnostics Market Trends
Table 12. Respiratory Infectious Disease Diagnostics Market Drivers
Table 13. Respiratory Infectious Disease Diagnostics Market Challenges
Table 14. Respiratory Infectious Disease Diagnostics Market Restraints
Table 15. Global Respiratory Infectious Disease Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Respiratory Infectious Disease Diagnostics Revenue Share by Players (2018-2023)
Table 17. Global Top Respiratory Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2022)
Table 18. Global Respiratory Infectious Disease Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Respiratory Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Respiratory Infectious Disease Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of Respiratory Infectious Disease Diagnostics, Product and Application
Table 22. Global Key Players of Respiratory Infectious Disease Diagnostics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Respiratory Infectious Disease Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Respiratory Infectious Disease Diagnostics Revenue Share by Application (2018-2023)
Table 30. Global Respiratory Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Respiratory Infectious Disease Diagnostics Revenue Share by Application (2024-2033)
Table 32. North America Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Respiratory Infectious Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Respiratory Infectious Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Respiratory Infectious Disease Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Respiratory Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Respiratory Infectious Disease Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Respiratory Infectious Disease Diagnostics Product
Table 67. Abbott Laboratories Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 68. Abbott Laboratories Recent Developments
Table 69. Thermo Fisher Scientific. Company Details
Table 70. Thermo Fisher Scientific. Business Overview
Table 71. Thermo Fisher Scientific. Respiratory Infectious Disease Diagnostics Product
Table 72. Thermo Fisher Scientific. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher Scientific. Recent Developments
Table 74. Koninklijke Philips Company Details
Table 75. Koninklijke Philips Business Overview
Table 76. Koninklijke Philips Respiratory Infectious Disease Diagnostics Product
Table 77. Koninklijke Philips Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Koninklijke Philips Recent Developments
Table 79. Cardinal Health Company Details
Table 80. Cardinal Health Business Overview
Table 81. Cardinal Health Respiratory Infectious Disease Diagnostics Product
Table 82. Cardinal Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 83. Cardinal Health Recent Developments
Table 84. COSMED Company Details
Table 85. COSMED Business Overview
Table 86. COSMED Respiratory Infectious Disease Diagnostics Product
Table 87. COSMED Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 88. COSMED Recent Developments
Table 89. Smiths Group Company Details
Table 90. Smiths Group Business Overview
Table 91. Smiths Group Respiratory Infectious Disease Diagnostics Product
Table 92. Smiths Group Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Smiths Group Recent Developments
Table 94. NIHON KOHDEN CORPORATION Company Details
Table 95. NIHON KOHDEN CORPORATION Business Overview
Table 96. NIHON KOHDEN CORPORATION Respiratory Infectious Disease Diagnostics Product
Table 97. NIHON KOHDEN CORPORATION Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 98. NIHON KOHDEN CORPORATION Recent Developments
Table 99. Becton Company Details
Table 100. Becton Business Overview
Table 101. Becton Respiratory Infectious Disease Diagnostics Product
Table 102. Becton Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Becton Recent Developments
Table 104. Dickinson Company Details
Table 105. Dickinson Business Overview
Table 106. Dickinson Respiratory Infectious Disease Diagnostics Product
Table 107. Dickinson Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Dickinson Recent Developments
Table 109. F.Hoffmann Company Details
Table 110. F.Hoffmann Business Overview
Table 111. F.Hoffmann Respiratory Infectious Disease Diagnostics Product
Table 112. F.Hoffmann Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 113. F.Hoffmann Recent Developments
Table 114. bioMérieux SA Company Details
Table 115. bioMérieux SA Business Overview
Table 116. bioMérieux SA Respiratory Infectious Disease Diagnostics Product
Table 117. bioMérieux SA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 118. bioMérieux SA Recent Developments
Table 119. Bio-Rad Laboratories, Inc. Company Details
Table 120. Bio-Rad Laboratories, Inc. Business Overview
Table 121. Bio-Rad Laboratories, Inc. Respiratory Infectious Disease Diagnostics Product
Table 122. Bio-Rad Laboratories, Inc. Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Bio-Rad Laboratories, Inc. Recent Developments
Table 124. Quidel Corporation Company Details
Table 125. Quidel Corporation Business Overview
Table 126. Quidel Corporation Respiratory Infectious Disease Diagnostics Product
Table 127. Quidel Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Quidel Corporation Recent Developments
Table 129. Siemens Healthcare GmbH Company Details
Table 130. Siemens Healthcare GmbH Business Overview
Table 131. Siemens Healthcare GmbH Respiratory Infectious Disease Diagnostics Product
Table 132. Siemens Healthcare GmbH Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Siemens Healthcare GmbH Recent Developments
Table 134. Danaher Company Details
Table 135. Danaher Business Overview
Table 136. Danaher Respiratory Infectious Disease Diagnostics Product
Table 137. Danaher Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Danaher Recent Developments
Table 139. Qiagen Company Details
Table 140. Qiagen Business Overview
Table 141. Qiagen Respiratory Infectious Disease Diagnostics Product
Table 142. Qiagen Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Qiagen Recent Developments
Table 144. GENERAL ELECTRIC COMPANY Company Details
Table 145. GENERAL ELECTRIC COMPANY Business Overview
Table 146. GENERAL ELECTRIC COMPANY Respiratory Infectious Disease Diagnostics Product
Table 147. GENERAL ELECTRIC COMPANY Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 148. GENERAL ELECTRIC COMPANY Recent Developments
Table 149. Medtronic Company Details
Table 150. Medtronic Business Overview
Table 151. Medtronic Respiratory Infectious Disease Diagnostics Product
Table 152. Medtronic Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 153. Medtronic Recent Developments
Table 154. Novartis AG Company Details
Table 155. Novartis AG Business Overview
Table 156. Novartis AG Respiratory Infectious Disease Diagnostics Product
Table 157. Novartis AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 158. Novartis AG Recent Developments
Table 159. Johnson & Johnson Services Inc Company Details
Table 160. Johnson & Johnson Services Inc Business Overview
Table 161. Johnson & Johnson Services Inc Respiratory Infectious Disease Diagnostics Product
Table 162. Johnson & Johnson Services Inc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 163. Johnson & Johnson Services Inc Recent Developments
Table 164. GlaxoSmithKline plc Company Details
Table 165. GlaxoSmithKline plc Business Overview
Table 166. GlaxoSmithKline plc Respiratory Infectious Disease Diagnostics Product
Table 167. GlaxoSmithKline plc Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 168. GlaxoSmithKline plc Recent Developments
Table 169. Drägerwerk AG & Co. KGaA Company Details
Table 170. Drägerwerk AG & Co. KGaA Business Overview
Table 171. Drägerwerk AG & Co. KGaA Respiratory Infectious Disease Diagnostics Product
Table 172. Drägerwerk AG & Co. KGaA Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 173. Drägerwerk AG & Co. KGaA Recent Developments
Table 174. GC Diagnostics Corporation Company Details
Table 175. GC Diagnostics Corporation Business Overview
Table 176. GC Diagnostics Corporation Respiratory Infectious Disease Diagnostics Product
Table 177. GC Diagnostics Corporation Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 178. GC Diagnostics Corporation Recent Developments
Table 179. Bayer AG Company Details
Table 180. Bayer AG Business Overview
Table 181. Bayer AG Respiratory Infectious Disease Diagnostics Product
Table 182. Bayer AG Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 183. Bayer AG Recent Developments
Table 184. Masimo Company Details
Table 185. Masimo Business Overview
Table 186. Masimo Respiratory Infectious Disease Diagnostics Product
Table 187. Masimo Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 188. Masimo Recent Developments
Table 189. Carestream Health Company Details
Table 190. Carestream Health Business Overview
Table 191. Carestream Health Respiratory Infectious Disease Diagnostics Product
Table 192. Carestream Health Revenue in Respiratory Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
Table 193. Carestream Health Recent Developments
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Respiratory Infectious Disease Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Mechanical Tests Features
Figure 4. Imaging Tests Features
Figure 5. In Vitro Diagnostics (IVD) Tests Features
Figure 6. Global Respiratory Infectious Disease Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Respiratory Infectious Disease Diagnostics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinical Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Respiratory Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Respiratory Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Respiratory Infectious Disease Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Respiratory Infectious Disease Diagnostics Market Share by Region: 2022 VS 2033
Figure 15. Global Respiratory Infectious Disease Diagnostics Market Share by Players in 2022
Figure 16. Global Top Respiratory Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Infectious Disease Diagnostics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Respiratory Infectious Disease Diagnostics Revenue in 2022
Figure 18. North America Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
Figure 20. North America Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
Figure 21. North America Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 22. United States Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Respiratory Infectious Disease Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
Figure 26. Europe Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
Figure 27. Europe Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 28. Germany Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Respiratory Infectious Disease Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
Figure 36. China Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
Figure 37. Asia Respiratory Infectious Disease Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
Figure 39. Asia Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
Figure 40. Asia Respiratory Infectious Disease Diagnostics Market Share by Region (2018-2033)
Figure 41. Japan Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Respiratory Infectious Disease Diagnostics Market Share by Country (2018-2033)
Figure 51. Brazil Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Respiratory Infectious Disease Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 58. Thermo Fisher Scientific. Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 59. Koninklijke Philips Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 60. Cardinal Health Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 61. COSMED Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 62. Smiths Group Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 63. NIHON KOHDEN CORPORATION Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 64. Becton Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 65. Dickinson Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 66. F.Hoffmann Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 67. bioMérieux SA Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 68. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 69. Quidel Corporation Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 70. Siemens Healthcare GmbH Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 71. Danaher Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 72. Qiagen Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 73. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 74. Medtronic Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 75. Novartis AG Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 76. Johnson & Johnson Services Inc Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 77. GlaxoSmithKline plc Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 78. Drägerwerk AG & Co. KGaA Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 79. GC Diagnostics Corporation Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 80. Bayer AG Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 81. Masimo Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 82. Carestream Health Revenue Growth Rate in Respiratory Infectious Disease Diagnostics Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed